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Abstract 
 Background. Immediately after the 
outbreak of novel influenza A (H1N1) in the United States of America and 
Mexico, World Health Organization declared a global pandemic (pH1N1). A 
global monitoring system was set up in Morocco to control the dissemination 
of the virus and its impact on the public health. This study aims to describe 
the epidemiological and clinical characteristics of influenza like illness (ILI) 
patients and confirmed pH1N1 cases diagnosed in the Research and Analysis 
Medical Laboratory (LRAM) between November 23rd 2009 and March 7th 
2010. Methods. A total of 300 nasopharyngeal swabs from ILI patients were 
screened for seasonal influenza A and pH1N1 viruses by real-time RT-PCR. 
For each patient, clinical and epidemiological information were recorded. 
Results. pH1N1 was confirmed in 149 ILI patients (49.7%). This study 
showed a peak in week 50/2009. The mean age of pH1N1 cases was 13.4 
years and children between 5 and 14 years are the most affected cases 
(82/149). The most common symptom was the cough reported in 83% of 
pH1N1 positive cases, followed by headache and asthenia. Among the 149 
pH1N1 confirmed cases, 10 had asthma and all of them are children. 
Conclusion. During the pandemic period, pH1N1 was the predominant 
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influenza A subtype. This study indicates that pH1N1 was widespread and 
the highest risk group is the children of school-going age (aged 5–14). These 
results can be used for future planning strategies for influenza and 
strengthening the influenza monitoring system for better management of the 
infection and limiting the development of complicated diseases. 
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Introduction 
 Influenza virus is a common human pathogen that has caused serious 
respiratory illness and death over the past century. It always had potential to 
cause widespread pandemics whenever a new type of Influenza strain 
appeared in the human population and then spread easily from person to 
person (Khanna et al., 2008). 
 Since the emergence of a novel influenza A/H1N1 in April 2009 in 
Mexico and the United States, sustained transmission worldwide occurred 
rapidly. This new influenza virus arose through the reassortment of a North 
American triple-reassortant swine influenza virus and a Eurasian swine 
influenza virus (Smith et al., 2009; Kuchipudi et al., 2009; Peiris et al., 2009; 
Lalle et al., 2010). 
 According to the World Health Organization (WHO) clinical 
definition, an influenza infection is an acute febrile respiratory illness with 
influenza-like symptoms including at least two of the following symptoms: 
fever > 38°C, and cough or sore throat in the absence of other diagnoses) 
(WHO, 2009a). According to the US CDC criteria (Centers for Disease 
Control and Prevention, Atlanta, USA), influenza infection was defined as 
fever ≥37.8 °C accompanied by at least one of the following respiratory 
symptoms: cough, sore throat, headache or muscle ache (CDC, 2009). 
 The WHO issued alerts about the emergence of pandemic (H1N1) on 
April 23, 2009. Less than 2 months later, WHO declared pandemic alert 
stage 6 on June 11, 2009 (WHO, 2009b). Immediately after the alerts, a 
national mandatory notification system was started in Morocco for influenza-
like illness (ILI) cases and hospitalized persons with pH1N1 in public and 
private institutions. Among The institutions assigned to be in charge of the 
diagnosis of pH1N1 were National Institute of Hygiene, Pasteur Institute of 
Morocco, The military hospital Mohammed V and the Research and 
Analysis Medical Laboratory (LRAM, Fraternelle de la Gendarmerie 
Royale). In the end of this study (10 March, 2010) 2.890 cases of influenza 
pH1N1have been identified and 63 have died (Moroccan Ministry of Health, 
2011). 
 The present study was planned to evaluate the prevalence and trend 
of emergence of pH1N1 virus in ILI cases diagnosed in the LRAM during 
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the epidemiologic period (November 23rd 2009 to March 7th 2010), and to 
describe the associating clinical symptoms of patients studied. 
 
Materials and methods 
Specimens 
 In this study, 300 clinical samples of nasopharyngeal swabs were 
recruited. Samples were collected from patients with influenza-like illness 
visiting the LRAM from Rabat region in Morocco. Influenza infection was 
defined according to WHO criteria. For all recruited patients, information on 
age, sex, date of specimen collection, illness symptoms and date of onset, 
and administration of antiviral treatment were recorded on appropriate 
questionnaire. All patients confirmed with pH1N1 were contacted and 
received a anti-influenza treatment. 
 
RNA extraction from clinical samples 
 RNA extraction from clinical samples was performed using the 
QIAamp Viral RNA Extraction mini Kit (Qiagen, Germany), according to 
the manufacturer’s instructions,  
 
RT PCR for screening of influenza pH1N1 viruses 
 The One step real-time RT-PCR was performed at an 7500 Fast Real-
Time PCR System (Applied Biosystems) according to the CDC protocol for 
the identification of swine influenza A(H1) viruses revision 2 (WHO, 
2009c).The reagents and positive control material were kindly provided by 
CDC. 
 Each RNA sample was tested for four sets of genes, which are: 
matrix protein gene segment for the identification of influenza A viruses, 
nucleoprotein gene segment for the identification of swine A influenza 
viruses, haemaglutinin gene segment for the subtyping of swine A H1 
viruses. Lastly, RNAse P gene segment was amplified to test the RNA 
extraction procedure, as well as the specimen content of human amplifiable 
genetic material and inhibition (WHO, 2009c). 
 
Statistical analysis 
 Statistical analysis was conducted using SPSS statistics 21, Fisher’s 
exact test was performed for statistical analysis, and differences were 
considered significant for P < 0.05. Odds ratio (OR) with Pearson’s chi-
squared test was used to show the significant age group, keeping 0–4 years 
as the comparison age group.  
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Results 
During the study period, from week 48/2009 to week 9/2010, swab 
samples from 300 patients suspected of contracting influenza were tested. 
Pandemic influenza A pH1N1 was detected in 149 cases (49.7%) whereas 
seasonal influenza A viruses were detected in only 14 cases (4.6%). Of the 
149 pH1N1 positive cases, 81 (54.40%) were women and 68 (45.60%) were 
men (M⁄F ratio 0.9:1). 
At the beginning of the study on November 23rd 2009, 23 pH1N1 
positive cases (15.4%) were registered the week 48/2009. Number of cases 
increased and reached the peak during the week 50/2009 with 58 pH1N1 
positive cases (38.9%) and then decreased progressively (Figure 1). 
 
Figure 1: Distribution of pH1N1 confirmed and negative cases during the pandemic period 
from November 23rd 2009 to March 7th 2010 
 
 A: Number of recruited ILI cases.  
 B: Percentage of pH1N1 positive and negative cases. Percntages 
were calculated according to total pH1N1 positive and negative cases 
registered during the pandemic season 
 Interestingly, during the first weeks of pandemic, the rate of detection 
of pH1N1 positive cases among ILI patients was higher than the rate of 
negative cases. After the week 51/2009, the opposite side was observed and 
ILI patients were diagnosed as pH1N1 negative. 
European Scientific Journal November  2014 edition vol.10, No.33 ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
327 
 Patients confirmed with pH1N1 ranged from 2 months to 72 years 
old. The means age of ILI and pH1N1 confirmed patients were 19 and 13.4 
years respectively. Distribution of pH1N1 infected cases according to age is 
reported in Table 1 and clearly showed that children between 5 and 14 years 
are the most affected by pH1N1 : 82⁄149 ( 55%, p = 0, OR = 5.25, CI 95% 
2.68-10.27). Of particular interest, 25 children less than 4 years were 
confirmed pH1N1 positive representing 16.78% of total positive cases (Table 
I). 
Table I: Distribution of suspected and pH1N1 cases according to the age 
Odds ratio; CI: confidence interval; *Chi-squared test: p = 0.05 
 
Clinical symptoms of all suspected cases and patients with pH1N1 
infected cases are reported in table II. The most common symptom was the 
cough reported in 83% of pH1N1 positive cases. Headache and asthenia 
were reported respectively in 57.7 % and 52.3 %. Interestingly, only 31 % of 
pH1N1 infected patients had fever. 
Table II. Assessment of clinical symptoms of patients with influenza-like illness and patients 
infected with influenza pH1N1 virus. 
 
Analysis of association between some risk factors and the infection 
with pH1N1 is reported in Table III. Among the 149 pH1N1 cases, only 15 
(10.06%) had at least one risk factor and the most prevalent were asthma 
reported 10 patients (6.71 %), allergic rhinitis in 3 cases and pregnancy in 2 
cases. Of particular interest, all the asthmatic cases are children. 
Age 
Group 
(years) 
Suspected 
cases 
pH1N1 positive 
cases P OR 95% CI 
N % N % 
< 4 65 21.67 25 16.78 - - --- --- 
5-14 107 35.67 82 55.03 0.000 5.248 2.683 10.266 
15- 21 24 8.00 15 10.07 0.047 2.667 1.015 7.004 
22- 40 65 21.67 21 14.09 0.464 0.764 0.371 1.571 
41- 60 31 10.33 5 3.36 0.032 0.308 0.105 0.906 
> 60 8 2.67 1 0.67 0.179 0.229 0.027 1.970 
Total 300  149      
Symptoms Ili patient (N = 300) pH1N1 patients (N = 149) 
N % N % 
Fever 62 21% 46 31% 
Cough 209 70% 123 83% 
Headache 144 48% 85 57% 
Asthenia 138 46% 78 52% 
Sore throat 91 30% 43 29% 
Muscle ache 91 30% 50 34% 
Vomiting 41 14% 26 17% 
Diarrhea 26 9% 10 7% 
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Table III. Risk factors distribution among ILI patients and confirmed pH1N1 cases 
 
Discussion 
 During the world pH1N1 pandemic, many epidemiologic studies 
were carried out worldwide to characterize the epidemiology of the virus to 
establish the global and specific maps of pH1N1 distribution, to elaborate 
specific countermeasures to be implemented.  
 Of particular interest was the early apparition of pH1N1 infected 
cases in North African countries. The first laboratory-confirmed pH1N1 case 
in Morocco was identified on June 10, 2009 in a 19-year-old woman 
travelling from Canada to Morocco, (Barakat et al., 2012). On December 
24th 2009 Morocco counted 2.806 cases of influenza pH1N1 and 45 have 
died. (Moroccan Ministry of Health, 2011). In Tunisia, 1181 admissions to 
hospital with severe illness have been reported and 170 confirmed cases of 
influenza pH1N1 with severe infection requiring hospital management in 
intensive care. A total of 28 pandemic H1N1 influenza-associated deaths 
were confirmed, and died from a clinically compatible illness or 
complications attributable to this infection (El Moussi, et al., 2013) 
 In this field, Morocco has implemented a national surveillance 
program to monitor the spread of pH1N1 and its impact on the public health. 
In the course of the surveillance study we conducted during the pandemic 
period, November 23rd 2009 to March 7th 2010, pH1N1 virus was not the 
only circulating strain detected. pH1N1 virus was identified in 49.7% of 
cases and seasonal influenza A viruses were detected in 4.6% of cases. The 
frequency of pH1N1 in our study population is in agreement with previous 
reported data in Morocco and worldwide. Indeed, Lahlou and coll. have 
detected pH1N1 in 40% of ILI patients (Lahlou, 2011). The prevalence of 
pH1N1 depends on the proximity of the origin sites of the pandemic and the 
close relationships between them. In Chile, 80% of ILI cases corresponded to 
pH1N1 (Dabanch et al., 2011). In the Mediterranean region, the frequency of 
pH1N1 varied between 30 and 50%. Rizzo et al. have reported that 40% of 
medically attended ILI cases in August 2009 in Italy were pH1N1 positive 
(Rizzo et al., 2010). Another study conducted in Portugal showed that 30.8% 
 
Ili patient 
N = 300 
pH1N1 patients 
N = 149 
Risk Factors No No  
Asthma 20 10 
Pregnancy 5 2 
Allergic rhinitis 3 3 
Diabetes 3 0 
Cardiopaty 3 0 
Renal failure 1 0 
obesity 1 0 
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of analyzed ILI patients were confirmed for pH1N1 (Duque et al., 2010). In 
France, many studies were conducted upon the pandemic is declared, and the 
peak of detection of pH1N1 in ILI patients (47%) was obtained in November 
2009 (Lainé et al., 2010; Malato et al., 2011). 
 In some countries, during the pandemic period, pH1N1 was the only 
identified and isolated virus among all ILI patients. However, after the 
pandemic period, other influenza viruses, like A(H3N2) and type-B viruses, 
were detected (Dapat et al., 2012). 
 Before the pH1N1 pandemic, the viral molecular detection was rarely 
applied for influenza diagnosis. In our laboratory, influenza detection and 
pH1N1 identification have started by the mid-November and the first ILI 
cases recruited were in the week 48/2009. Distribution of recruited ILI 
patients and pH1N1 confirmed cases presented a peak in the second week of 
December 2009 and the number of registered cases decreased significantly. 
Other referent centers in Morocco and the global pandemic surveillance 
program have reported the same results, and confirm the disappearance of 
pH1N1 in favor of seasonal influenza (Barakat et al., 2012; Lahlou et al., 
2011; Moroccan Ministry of Health, 2011). 
 Worldwide, there is evidence that age was a risk factor for severe 
influenza and death. Patients >60 years of age and <5 years of age were at a 
higher risk for severe disease, and patients >60 years of age were at a higher 
risk for death. At least 1 concurrent condition was identified as a risk factor 
for death from pandemic (H1N1) 2009. In this study, the highest rate of 
pH1N1 positivity was observed among children under 14 years old, persons 
≥60 years of age were least affected. These results are in agreement with 
reported data worldwide. In the USA 60% of the pH1N1 confirmed patients 
were less than 18 years (Kwan- Gett et al., 2009), whereas in Japan, 88.5% 
of cases of 2009A ⁄H1N1 were reported in persons <20 years of age, 
(Kamigaki et al., 2009). In United Kingdom, children under 16 years were 
more susceptible to infection in the households (Ghani, et al., 2009). In 
Mexico, as for other Latin American countries, pH1N1 was more 
predominant in younger people less than 15 Years (Perez-Padilla et al., 
2009). The high frequency of pH1N1 among younger people is mainly due 
to the high exposure rates among school-aged children 
 Of particular interest, limited number of elderly people was suspected 
to have influenza and among them only one case was confirmed positive for 
pH1N1. This hypothesis is supported by subsequent studies (CDC, 2010). 
Many studies have reported that during the influenza pandemic, risk for 
illness in this age group was low but risk for severe disease and death was 
higher than in the other groups, independent of underlying diseases 
(Dabanch et al., 2011). 
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 In contrast to seasonal influenza, severe disease from pandemic 
H1N1 seems concentrated in older children and young adults, with almost no 
cases reported in patients older than 60 yrs, suggesting partial immunity to 
the virus in the older population (Rothberg et al., 2010). 
 The most common symptoms of patients with pH1N1 were cough 
(81.9%), fever (59.7%), headache (57.7%), Asthenia (52.3%), sore throat 
(34.2%), muscle pain (33.6%), vomiting (17.4%) and diarrhea (6.0%). The 
same symptoms were reported for pH1N1 patients and ILI patients infected 
with other viruses, and clinical symptoms of pH1N1 are typical to the 
seasonal influenza. 
 Worldwide, Fever and cough are the most reported symptoms. 
Indeed, Fever was reported in 56 to 100% of pH1N1 infected cases, whereas 
cough was reported in 54 to 90 % of cases (Biswas et al., 2010; Al Mazroa et 
al., 2010; Humne, A. Y. et al., 2013; Lessler et al., 2009). Clinical symptoms 
and their aggressiveness must be taken with precaution. In fact, it’s widely 
accepted that clinical signs can vary significantly according to the age of the 
patient and the presence of underlying diseases.   
 Differences in clinical features between influenza A H1N1, A H3N2, 
and B in adult patients was already reported and showed that fever, 
headache, general malaise and sore throat were equally frequent in both of 
them (Kaji et al., 2003). Thus, clinical symptoms are not a good marker for 
good discrimination between pH1N1 and seasonal influenza. 
 Moreover, it’s widely accepted that some factors may be at risk for 
contracting influenza viruses and developing complicated diseases such as 
pneumonia which is the most complicated diseases of the H1N1 outbreak 
strain. In this field, we have investigated the association between pH1N1 
infection and some risk factors. Interestingly, among the 149 pH1N1 positive 
cases, asthma, allergic rhinitis and pregnancy were the only reported risk 
factors and were present in 10, 3 and 2 cases, respectively, and all asthmatic 
cases are the children. These results are in agreement with previous studies 
that have clearly showed the high significant risk factor for severe disease in 
children with asthma (O’Riordan et al., 2010). Moreover, patients having 
underlying conditions, such as respiratory diseases including asthma, require 
immediate hospitalization (Jain et al., 2009). 
 Worldwide, pregnancy is also reported as a major risk factor for 
contracting pH1N1 and developing severe influenza disease. Because of their 
vulnerability, particular attention must be done to pregnant women, 
especially in their second and third trimester, and treatment with anti-
influenza drugs have to be applied promptly (Jamieson et al., 2009). 
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Conclusion 
 During the 2009-2010 influenza season, pH1N1 was the predominant 
virus subtype in Morocco, and the highest rate of pH1N1 infection was in 
children under 14 years. The limited numbers of suspected cases with 
influenza like illness and pH1N1 confirmed cases is mainly due to the 
efficacy of the established monitoring strategy of influenza surveillance in 
Morocco and efficient management of infected cases limiting the 
dissemination of the virus in the whole population. Moreover, intense media 
coverage that accompanied the pandemic has contributed to enhance the 
awareness of the whole population on the disease and to inform them on how 
to protect themselves against the virus, reducing the spread of the epidemic. 
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